A17.8 Other tuberculosis of nervous system

Name of the Condition

• Other tuberculosis of nervous system

Summary

Other tuberculosis of the nervous system refers to tuberculosis (TB) infections affecting the central nervous system (CNS) that do not fall under more specific categories like tuberculous meningitis or tuberculoma. This condition involves Mycobacterium tuberculosis infection in areas such as the brain, spinal cord, or meninges, leading to inflammation and potential neurological complications. Prompt diagnosis and treatment are critical to prevent severe outcomes.

Causes

Other tuberculosis of the nervous system is caused by the spread of Mycobacterium tuberculosis from a primary TB infection, typically in the lungs, to the CNS. The bacteria can reach the nervous system through the bloodstream or by direct extension from adjacent infected tissues. The infection may manifest in various forms, including granulomatous lesions or inflammatory processes, depending on the site and extent of involvement.

Risk Factors

• Active pulmonary tuberculosis or other extrapulmonary TB
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Malnutrition or chronic illness
• Recent TB exposure or infection
• Lack of access to TB treatment or preventive care

Symptoms

• Persistent headache
• Fever and night sweats
• Neurological deficits (e.g., weakness, numbness, confusion)
• Seizures
• Changes in mental status
• Stiff neck (if meninges are involved)
• Nausea and vomiting

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging (e.g., MRI or CT scans), and laboratory testing. Cerebrospinal fluid (CSF) analysis may reveal abnormalities consistent with TB infection, such as elevated protein, low glucose, or the presence of Mycobacterium tuberculosis via culture or molecular testing. Biopsy of affected tissue may be necessary in some cases to confirm the diagnosis.

Treatment Options

Treatment typically includes a prolonged course of anti-tuberculosis medications, such as isoniazid, rifampin, pyrazinamide, and ethambutol, often administered for 6–12 months. Corticosteroids may be used to reduce inflammation, especially in cases involving the meninges. Close monitoring for drug resistance and adherence to the treatment regimen is essential.

Prognosis and Follow-Up

Prognosis depends on the severity of the infection, timeliness of treatment, and the patient’s overall health. Early intervention improves outcomes, but neurological damage may be irreversible in advanced cases. Follow-up care includes regular monitoring for treatment response, potential side effects of medications, and long-term neurological assessments.

Complications

• Permanent neurological deficits (e.g., paralysis, cognitive impairment)
• Hydrocephalus
• Seizure disorders
• Recurrent infection
• Drug resistance

Lifestyle & Prevention

• Complete the full course of prescribed TB medications to prevent recurrence or resistance.
• Maintain good nutrition and overall health to support immune function.
• Avoid exposure to individuals with active TB, especially in high-risk settings.
• Follow public health guidelines for TB screening and preventive therapy if at risk.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe headache, fever, confusion, weakness, or other neurological symptoms, especially if there is a known or suspected TB exposure. Early evaluation is critical to prevent complications.

Tips for Medical Coders

Document the specific site and nature of the nervous system involvement (e.g., brain, spinal cord, meninges) to support the use of code A17.8. Include details about diagnostic findings, treatment, and any associated complications to ensure accurate coding and clinical correlation.